H.R. 467 · 117th Congress
Protecting Patient Access to Lifesaving COVID–19 Drugs Act of 2021
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
GonzalezSponsor6 cosponsors · 6 D
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Protecting Patient Access to Lifesaving COVID-19 Drugs Act of 2021
What it does: CRS summary · Introduced in House · Jan 25, 2021
Protecting Patient Access to Lifesaving COVID-19 Drugs Act of 2021
This bill requires health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) antibody treatment at no cost for individuals who have tested positive for the virus.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Protecting Patient Access to Lifesaving COVID–19 Drugs Act of 2021
Latest action (Feb 2, 2021): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jan 25, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.